A nationwide survey has found strong public belief in vaccines. Almost 90 per cent of Ghanaians surveyed expressed confidence in vaccines. More than 94 per cent believe every citizen should have access to vaccines. The survey was conducted by the National Vaccine Institute. It covered all 16 regions of Ghana.
This high confidence is a major boost for Ghana's goal of producing its own vaccines locally. The country aims to start this production by 2027. The study analysed 13,905 responses. It found that over 71 per cent of Ghanaians would accept vaccines made in Ghana. They trust healthcare professionals and regulatory bodies. Over 87 per cent trust doctors and nurses. The Ghana Health Service and Food and Drugs Authority also earned high trust.
This public trust provides a solid base for Ghana's vaccine manufacturing plans. It aligns with the African Union's goal. The union wants Africa to produce 60 per cent of its vaccines by 2040. This initiative aims for vaccine self-sufficiency and innovation. It also contributes to national health security.
Dr. Sodzi Sodzi-Tettey, CEO of the National Vaccine Institute, called the findings encouraging. He stressed the importance of clear communication. He also noted the need for smart policies. Public confidence is strong, but Ghana must bridge the awareness gap. Addressing misinformation and regional differences is key. Operational issues can also affect public acceptance.
A significant finding is the low public awareness of Ghana's vaccine manufacturing plans. Only 14 per cent of respondents knew the country was building local vaccine production capacity. This suggests a need for a national education campaign. Such a campaign would combat false information. It would also help citizens feel more involved in the initiative.
The survey also noted differences between regions. Highly urban areas like Greater Accra showed lower acceptance. Rural communities in northern Ghana and the Oti Region showed higher trust. This might be due to access to information or cultural factors. Many respondents expressed national pride in the idea of local vaccine production.
However, some concerns were raised. These include the cost of vaccines. Long distances to vaccination centres are another barrier. Weaknesses in storing and transporting vaccines also pose challenges. This is especially true for rural areas lacking proper cold chain systems. These are key issues that need attention for successful local production and distribution.